Assistant Professor
The University of Hong Kong, Hong Kong
Dr. Shuofeng Yuan is currently an Assistant Professor in HKU Department of Microbiology. By focusing on small-molecule lead compounds that can be delivered orally and are cheaper and easier for patients to access, his efforts aim to help ensure the world is prepared to quickly develop and equitably deploy effective, accessible antiviral treatments when a pandemic threat emerges. By rewiring virus-induced lipidomic abnormity, he and colleagues discovered novel druggable factors such as sterol regulatory-element binding proteins (SREBPs) and Diglyceride acyltransferase (DGAT) for broad-spectrum antiviral therapy. Dr. Yuan has filed >10 patents with novel antivirals for emerging infectious diseases including influenza, zika and COVID-19. He is recognized as the worldwide “Highly Cited Researchers” 2021 and 2022 by Clarivate and published >40 first/co-first/corresponding-authored original research articles in the best journals including Nature and Science. Dr. Yuan recently received the Young Investigator Award by Pathogens Journal.